直到Vosoritide的获批，才让ACH治疗迈入一个全新的靶向治疗时代。它是一种C型利钠肽(CNP)类似物，通过结合NPR-B进而降低FGFR3的活性来促进生长。临床结果试验显示：相较于安慰剂，每日皮下注射15 μg/kg的Vosoritide，受试者平均年身高增加了1.57厘米。
[&:first-child]:overflow-hidden [&:first-child]:max-h-full"
，推荐阅读91视频获取更多信息
Nailed unit economics (CAC, margins, LTV).
Tiny Footprint: Our HH-Routing data adds only 0.5% to 1% to OsmAnd's already incredibly compact map sizes. The entire planet's car routing data is around 800MB!